tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Philogen Withdraws Nidlegy™ Application from EMA, Plans Resubmission
PremiumCompany AnnouncementsPhilogen Withdraws Nidlegy™ Application from EMA, Plans Resubmission
3M ago
Philochem Licenses Prostate Cancer Agent to RayzeBio in $1.35 Billion Deal
Premium
Company Announcements
Philochem Licenses Prostate Cancer Agent to RayzeBio in $1.35 Billion Deal
4M ago
Philogen Updates on Share Buyback Program
Premium
Company Announcements
Philogen Updates on Share Buyback Program
4M ago
Philogen S.p.A. Reports Strong Financial Position and Progress in Clinical Trials
PremiumCompany AnnouncementsPhilogen S.p.A. Reports Strong Financial Position and Progress in Clinical Trials
5M ago
Philogen S.p.A. Approves 2024 Financials and Appoints New Board
Premium
Company Announcements
Philogen S.p.A. Approves 2024 Financials and Appoints New Board
5M ago
Philogen S.p.A. Advances Share Buyback Program with Latest Acquisition
Premium
Company Announcements
Philogen S.p.A. Advances Share Buyback Program with Latest Acquisition
6M ago
Philogen Publishes Shareholders’ Meeting Documentation for April 2025
PremiumCompany AnnouncementsPhilogen Publishes Shareholders’ Meeting Documentation for April 2025
6M ago
Philogen S.p.A. Achieves Record Profits and Advances Cancer Therapy Pipeline
Premium
Company Announcements
Philogen S.p.A. Achieves Record Profits and Advances Cancer Therapy Pipeline
6M ago
Philogen S.p.A. Announces Shareholder Meeting to Discuss Financial and Governance Strategies
Premium
Company Announcements
Philogen S.p.A. Announces Shareholder Meeting to Discuss Financial and Governance Strategies
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100